mecamylamine has been researched along with Asphyxia in 2 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Asphyxia: A pathological condition caused by lack of oxygen, manifested in impending or actual cessation of life.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zakharova, EI | 1 |
| Dudchenko, AM | 1 |
| Germanova, EL | 1 |
| Eyzaguirre, C | 1 |
| Nishi, K | 1 |
2 other studies available for mecamylamine and Asphyxia
| Article | Year |
|---|---|
Effects of preconditioning on the resistance to acute hypobaric hypoxia and their correction with selective antagonists of nicotinic receptors.
Topics: Aconitine; Adaptation, Physiological; Air Pressure; Animals; Asphyxia; Hypoxia; Male; Mecamylamine; | 2011 |
Further study on mass receptor potential of carotid body chemosensors.
Topics: Acetylcholine; Animals; Asphyxia; Atropine; Carotid Body; Cats; Cyanides; Dibucaine; Electrophysiolo | 1974 |